A research team has determined the risk factors for moderate to severe hepatic steatosis among patients with HIV by comparing the prevalence rates of hepatic steatosis among patients with HIV vs without...
The International Antiviral Society-USA has released an update to its recommendations for treating and preventing HIV infection with antiretroviral drugs.
Although it is well known that patients with HIV have higher rates of incident heart failure and worse outcomes after an event, the role of NT-proBNP concentrations has not been explored. New research...
In a recent study, researchers sought to investigate the effects of statin therapy on inflammatory and cardiovascular proteins in patients with and without HIV.
Researchers investigated whether current and lifetime alcohol use is associated with markers of liver disease among individuals with HIV and hepatitis C virus.
The FDA has approved a treatment option for adults with multidrug resistant HIV infection, marking a “new class of antiretroviral medications” for this patient population.
New findings published in HIV Medicine have shed light on distinct risks, clinical characteristics, and outcomes at the time of HIV diagnosis among Canadian patients younger than vs older than age 50...
The US Food and Drug Administration approved a drug for the treatment of HIV-1 infection in conjunction with other antiretroviral therapies among children aged at least 4 weeks who weigh at least 3 kg. ...
The Centers for Disease Control and Prevention has released guidance on what to consider when evaluating adolescents for pre-exposure prophylaxis for the prevention of HIV.
